Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...

A new pancreatic cancer treatment targeting the KRAS gene mutation represents a major breakthrough, offering the first ...

New KRAS-targeting drug for metastatic pancreatic cancer nearly doubles second-line survival; expert explains impact, side effects, next trials.

The drug will be used in conjunction with other treatments that yield results.

Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune ...

Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...

A new drug is doubling survival time for pancreatic cancer patients. Daraxonrasib, the drug being taken by former Sen. Ben ...

Revolution Medicines' application for a drug to treat metastatic pancreatic cancer was accepted for review by the Food and Drug Administration.

Background New-onset diabetes (NOD) increases the risk of pancreatic cancer. Previous studies have mainly focused on the ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and Drug ...

The Fred and Pamela Buffett Cancer Center is now enrolling patients in an expanded access program for investigational drug ...